JavaScript отключён. Чтобы полноценно использовать наш сайт, включите JavaScript в своём браузере.

Ответить в теме

Сообщение: <blockquote data-quote="expinge" data-source="post: 720049" data-attributes="member: 10992"><p>Long term follow up data from a large international phase III trial shows that postmenopausal women with early stage hormone receptor positive breast cancer who received 2 to 3 years of tamoxifen and then switched to the drug exemestane Aromasin for a total of 5 years of adjuvant hormone therapy experienced a delay in disease recurrence and a survival advantage, compared with women who took tamoxifen for 5 years <a href=<a href="https://buycialis.sbs">https://buycialis.sbs</a>>cialis vs viagra</a></p></blockquote><p></p>